SCHEMBL30960992

SCHEMBL30960992

CCN(c1ccccc1)c1nc(Cl)nc2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.51
PDGFRB P09619 1/20 0.51
KDR P35968 1/20 0.51
GBA1 P04062 1/20 0.50
ALDH1A1 P00352 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
ACP1 P24666 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
CSF1R P07333 2/20 0.43
KDM4E B2RXH2 1/20 0.42
PDE5A O76074 2/20 0.41
MAPT P10636 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
APP P05067 1/20 0.41
APAF1 O14727 1/20 0.40
CASP3 P42574 1/20 0.40
CASP6 P55212 1/20 0.40
SENP8 Q96LD8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3122164 1.00 EGFR (0.51) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL30961029 0.88 GBA1 (0.51) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL23576925 0.88 GBA1 (0.51) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL3113479 0.88 EGFR (0.70) EGFRPDGFRBKDRGBA1CASP3
SCHEMBL30013919 0.85 EGFR (0.54) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL23577358 0.85 EGFR (0.54) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL23576711 0.85 RXFP1 (0.40) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL30961063 0.85 RXFP1 (0.40) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL23576765 0.83 EGFR (0.43) EGFRPDGFRBKDRGBA1ALDH1A1
SCHEMBL29909253 0.83 EGFR (0.43) EGFRPDGFRBKDRGBA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK EGFR 1239/4885PDGFRB 1157/4885KDR 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.